nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Topotecan—lung cancer	0.0941	0.142	CbGbCtD
Tasosartan—CYP3A4—Gefitinib—lung cancer	0.0861	0.13	CbGbCtD
Tasosartan—CYP3A4—Teniposide—lung cancer	0.0834	0.126	CbGbCtD
Tasosartan—CYP3A4—Vinorelbine—lung cancer	0.0663	0.1	CbGbCtD
Tasosartan—CYP3A4—Crizotinib—lung cancer	0.0527	0.0796	CbGbCtD
Tasosartan—CYP3A4—Erlotinib—lung cancer	0.0509	0.0768	CbGbCtD
Tasosartan—CYP3A4—Paclitaxel—lung cancer	0.0466	0.0703	CbGbCtD
Tasosartan—CYP3A4—Irinotecan—lung cancer	0.0459	0.0694	CbGbCtD
Tasosartan—CYP3A4—Vinblastine—lung cancer	0.0409	0.0617	CbGbCtD
Tasosartan—CYP3A4—Etoposide—lung cancer	0.0368	0.0556	CbGbCtD
Tasosartan—CYP3A4—Docetaxel—lung cancer	0.0337	0.0508	CbGbCtD
Tasosartan—AGTR2—respiratory system—lung cancer	0.0252	0.447	CbGeAlD
Tasosartan—CYP3A4—Doxorubicin—lung cancer	0.0251	0.0379	CbGbCtD
Tasosartan—AGTR2—lung—lung cancer	0.0134	0.237	CbGeAlD
Tasosartan—Irbesartan—JUN—lung cancer	0.00709	0.525	CrCbGaD
Tasosartan—AGTR1—epithelium—lung cancer	0.00472	0.0836	CbGeAlD
Tasosartan—AGTR1—trachea—lung cancer	0.00418	0.0739	CbGeAlD
Tasosartan—AGTR1—cardiac atrium—lung cancer	0.00392	0.0694	CbGeAlD
Tasosartan—AGTR1—lung—lung cancer	0.003	0.0531	CbGeAlD
Tasosartan—Losartan—UGT1A1—lung cancer	0.00274	0.203	CrCbGaD
Tasosartan—AGTR1—lymph node—lung cancer	0.00205	0.0363	CbGeAlD
Tasosartan—Valsartan—ALB—lung cancer	0.00137	0.102	CrCbGaD
Tasosartan—Candesartan—ABCB1—lung cancer	0.000993	0.0736	CrCbGaD
Tasosartan—Losartan—ALB—lung cancer	0.000671	0.0497	CrCbGaD
Tasosartan—Losartan—ABCB1—lung cancer	0.00064	0.0474	CrCbGaD
Tasosartan—AGTR1—Signaling Pathways—GIPR—lung cancer	0.000272	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADCY1—lung cancer	0.000272	0.00102	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000271	0.00101	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000268	0.001	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000267	0.000998	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP2R1B—lung cancer	0.000265	0.00099	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000264	0.000987	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—lung cancer	0.000264	0.000987	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TERT—lung cancer	0.000263	0.000983	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ANXA1—lung cancer	0.000262	0.000977	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000261	0.000975	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGFR1—lung cancer	0.000255	0.000955	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SDC4—lung cancer	0.000254	0.00095	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PTHLH—lung cancer	0.000253	0.000944	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000252	0.000941	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIF1A—lung cancer	0.000252	0.00094	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.00025	0.000933	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DUSP3—lung cancer	0.000249	0.000931	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—APP—lung cancer	0.000248	0.000927	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RHEB—lung cancer	0.000244	0.000913	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOA1—lung cancer	0.000243	0.000907	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KDR—lung cancer	0.000241	0.000899	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000239	0.000893	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000238	0.000889	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ANXA1—lung cancer	0.000237	0.000888	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000234	0.000875	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM8—lung cancer	0.000232	0.000865	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000231	0.000863	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.00023	0.000861	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000227	0.00085	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—POMC—lung cancer	0.000227	0.000847	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—APP—lung cancer	0.000225	0.000841	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SKI—lung cancer	0.000224	0.000838	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CG—lung cancer	0.000222	0.000828	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—lung cancer	0.000222	0.000828	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KIT—lung cancer	0.000222	0.000828	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—NRAS—lung cancer	0.000222	0.000828	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PIK3CA—lung cancer	0.000221	0.000825	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000219	0.00082	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGF—lung cancer	0.000219	0.000819	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.000215	0.000803	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK3—lung cancer	0.000212	0.000793	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—POMC—lung cancer	0.000211	0.000788	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BRAF—lung cancer	0.000208	0.000779	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000207	0.000772	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6R—lung cancer	0.000206	0.000769	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CREBBP—lung cancer	0.000205	0.000768	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—lung cancer	0.000202	0.000755	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000202	0.000754	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.000199	0.000744	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000197	0.000737	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAP2K1—lung cancer	0.000196	0.000733	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CD—lung cancer	0.000195	0.000728	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PXN—lung cancer	0.000195	0.000728	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000193	0.000722	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—lung cancer	0.000193	0.000721	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AVP—lung cancer	0.000193	0.000721	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GCLC—lung cancer	0.000191	0.000713	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.000191	0.000713	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—lung cancer	0.000191	0.000713	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OXTR—lung cancer	0.000191	0.000713	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRP—lung cancer	0.000191	0.000713	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKR1C1—lung cancer	0.000191	0.000713	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000183	0.000682	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNG11—lung cancer	0.000179	0.000667	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—lung cancer	0.000175	0.000656	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—lung cancer	0.000175	0.000655	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AVP—lung cancer	0.000175	0.000654	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000175	0.000653	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MDM2—lung cancer	0.000175	0.000652	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RAF1—lung cancer	0.000174	0.00065	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB2—lung cancer	0.000172	0.000643	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFC—lung cancer	0.00017	0.000635	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MTOR—lung cancer	0.00017	0.000635	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CB—lung cancer	0.00017	0.000635	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000164	0.000612	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—lung cancer	0.000163	0.00061	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2E1—lung cancer	0.000162	0.000606	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—lung cancer	0.000162	0.000606	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADCY1—lung cancer	0.000161	0.0006	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	0.00016	0.000598	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—lung cancer	0.000158	0.000589	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SMARCA4—lung cancer	0.000156	0.000585	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP2R1B—lung cancer	0.000156	0.000585	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—lung cancer	0.000156	0.000584	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—lung cancer	0.000156	0.000583	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—lung cancer	0.000155	0.00058	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCND1—lung cancer	0.000152	0.000568	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUN—lung cancer	0.000152	0.000567	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HSPB1—lung cancer	0.000151	0.000564	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTHLH—lung cancer	0.000149	0.000558	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—lung cancer	0.000148	0.000552	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1A—lung cancer	0.000147	0.00055	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—lung cancer	0.000147	0.000548	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—lung cancer	0.000143	0.000535	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ANXA1—lung cancer	0.00014	0.000524	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EP300—lung cancer	0.00014	0.000523	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SRC—lung cancer	0.000136	0.000509	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FLT1—lung cancer	0.000136	0.000508	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CG—lung cancer	0.000135	0.000503	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—lung cancer	0.000134	0.0005	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APP—lung cancer	0.000133	0.000497	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH3—lung cancer	0.000133	0.000497	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—lung cancer	0.000133	0.000495	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	0.000132	0.000493	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF9—lung cancer	0.000132	0.000493	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—lung cancer	0.000131	0.00049	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NRAS—lung cancer	0.000131	0.000489	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—POMC—lung cancer	0.000128	0.000479	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUNB—lung cancer	0.000126	0.000471	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK3—lung cancer	0.000125	0.000469	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—lung cancer	0.000123	0.00046	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CG—lung cancer	0.000122	0.000457	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—lung cancer	0.000122	0.000456	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	0.000121	0.000453	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—lung cancer	0.000119	0.000446	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CD—lung cancer	0.000118	0.000442	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP1A1—lung cancer	0.000117	0.000436	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—POMC—lung cancer	0.000116	0.000435	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	0.000115	0.00043	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STK11—lung cancer	0.000114	0.000427	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6R—lung cancer	0.000114	0.000424	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—lung cancer	0.000113	0.000421	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FOXO3—lung cancer	0.00011	0.000413	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAP2K1—lung cancer	0.000108	0.000404	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CD—lung cancer	0.000107	0.000402	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—lung cancer	0.000104	0.000387	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AVP—lung cancer	0.000103	0.000387	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CB—lung cancer	0.000103	0.000385	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COL4A3BP—lung cancer	0.000103	0.000383	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AZIN2—lung cancer	0.000103	0.000383	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—lung cancer	0.0001	0.000374	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1R—lung cancer	9.96e-05	0.000372	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—lung cancer	9.91e-05	0.00037	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HES1—lung cancer	9.78e-05	0.000366	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RAF1—lung cancer	9.59e-05	0.000359	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—lung cancer	9.58e-05	0.000358	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—lung cancer	9.47e-05	0.000354	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CB—lung cancer	9.37e-05	0.00035	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—lung cancer	9.17e-05	0.000343	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—lung cancer	9e-05	0.000336	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB3—lung cancer	8.94e-05	0.000334	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ATP5H—lung cancer	8.72e-05	0.000326	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—POMC—lung cancer	8.69e-05	0.000325	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—lung cancer	8.6e-05	0.000321	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TERT—lung cancer	8.57e-05	0.00032	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—lung cancer	8.46e-05	0.000316	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGFR1—lung cancer	8.32e-05	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIF1A—lung cancer	8.2e-05	0.000306	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOA1—lung cancer	7.91e-05	0.000296	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—lung cancer	7.84e-05	0.000293	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLBD1—lung cancer	7.77e-05	0.00029	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CG—lung cancer	7.22e-05	0.00027	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KIT—lung cancer	7.22e-05	0.00027	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—lung cancer	7.22e-05	0.00027	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NRAS—lung cancer	7.22e-05	0.00027	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGF—lung cancer	7.14e-05	0.000267	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD17B10—lung cancer	7.11e-05	0.000266	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK3—lung cancer	6.92e-05	0.000258	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—POMC—lung cancer	6.87e-05	0.000257	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BRAF—lung cancer	6.79e-05	0.000254	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6R—lung cancer	6.71e-05	0.000251	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CREBBP—lung cancer	6.69e-05	0.00025	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CKB—lung cancer	6.61e-05	0.000247	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—lung cancer	6.58e-05	0.000246	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAP2K1—lung cancer	6.39e-05	0.000239	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CD—lung cancer	6.35e-05	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—lung cancer	6.29e-05	0.000235	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—lung cancer	6.21e-05	0.000232	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM2—lung cancer	6.21e-05	0.000232	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CNDP2—lung cancer	6.21e-05	0.000232	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTMR3—lung cancer	6.04e-05	0.000226	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PGAM1—lung cancer	5.89e-05	0.00022	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—lung cancer	5.71e-05	0.000213	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MDM2—lung cancer	5.69e-05	0.000213	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RAF1—lung cancer	5.67e-05	0.000212	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2A7—lung cancer	5.62e-05	0.00021	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB2—lung cancer	5.61e-05	0.00021	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTOR—lung cancer	5.53e-05	0.000207	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CB—lung cancer	5.53e-05	0.000207	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SDC4—lung cancer	5.5e-05	0.000205	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—lung cancer	5.32e-05	0.000199	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—lung cancer	5.28e-05	0.000197	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—lung cancer	5.14e-05	0.000192	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—lung cancer	5.09e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—lung cancer	5.08e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—lung cancer	5.06e-05	0.000189	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA3—lung cancer	5.01e-05	0.000187	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—RRM1—lung cancer	5.01e-05	0.000187	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCND1—lung cancer	4.95e-05	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUN—lung cancer	4.94e-05	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—lung cancer	4.81e-05	0.00018	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1A—lung cancer	4.79e-05	0.000179	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—lung cancer	4.78e-05	0.000179	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—B4GALT5—lung cancer	4.71e-05	0.000176	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—lung cancer	4.66e-05	0.000174	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA4—lung cancer	4.58e-05	0.000171	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EP300—lung cancer	4.56e-05	0.00017	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA2—lung cancer	4.46e-05	0.000167	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SRC—lung cancer	4.43e-05	0.000166	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—lung cancer	4.32e-05	0.000161	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA1—lung cancer	4.31e-05	0.000161	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—lung cancer	4.28e-05	0.00016	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRAS—lung cancer	4.27e-05	0.000159	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCC3—lung cancer	4.26e-05	0.000159	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKR1C1—lung cancer	4.12e-05	0.000154	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK3—lung cancer	4.09e-05	0.000153	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UGT1A1—lung cancer	4e-05	0.00015	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—lung cancer	3.97e-05	0.000149	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—lung cancer	3.89e-05	0.000145	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GNG11—lung cancer	3.86e-05	0.000144	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDOA—lung cancer	3.68e-05	0.000137	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—lung cancer	3.67e-05	0.000137	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NCOA3—lung cancer	3.57e-05	0.000133	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADCY1—lung cancer	3.47e-05	0.00013	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCG2—lung cancer	3.47e-05	0.00013	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ENO2—lung cancer	3.4e-05	0.000127	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HPGDS—lung cancer	3.4e-05	0.000127	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.38e-05	0.000126	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—lung cancer	3.37e-05	0.000126	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—lung cancer	3.3e-05	0.000123	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2A6—lung cancer	3.26e-05	0.000122	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCLC—lung cancer	3.26e-05	0.000122	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—lung cancer	3.26e-05	0.000122	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—lung cancer	3.12e-05	0.000117	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ENO1—lung cancer	3.09e-05	0.000116	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—lung cancer	2.99e-05	0.000112	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2E1—lung cancer	2.77e-05	0.000104	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—lung cancer	2.76e-05	0.000103	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NQO1—lung cancer	2.74e-05	0.000103	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—STK11—lung cancer	2.47e-05	9.24e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—lung cancer	2.29e-05	8.55e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—lung cancer	2.23e-05	8.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCB1—lung cancer	2.17e-05	8.1e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TYMS—lung cancer	2.13e-05	7.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—lung cancer	2.1e-05	7.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP1A1—lung cancer	1.99e-05	7.45e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ERCC2—lung cancer	1.98e-05	7.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOA1—lung cancer	1.71e-05	6.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CG—lung cancer	1.56e-05	5.84e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—POMC—lung cancer	1.49e-05	5.56e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CREBBP—lung cancer	1.45e-05	5.41e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CD—lung cancer	1.37e-05	5.13e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—lung cancer	1.36e-05	5.06e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CB—lung cancer	1.2e-05	4.47e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—lung cancer	1.19e-05	4.43e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—lung cancer	1.03e-05	3.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EP300—lung cancer	9.86e-06	3.69e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—lung cancer	7.29e-06	2.73e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—lung cancer	5.96e-06	2.23e-05	CbGpPWpGaD
